LPT3-04™ Weight Loss Agent
Background. LPT3-04™ is Oragenics' small molecule weight-loss agent. As a natural substance, LPT3-04™ is orally available and has an excellent safety and tolerability profile. The prevalence of people who are overweight has increased significantly in the past few decades, with huge public health costs attached to it. Only a small number of products are currently marketed that effectively help promote weight loss. The commercial potential for this novel small molecule, and its analogs, for regulation of body weight is significant.
Technical Background. Cell culture studies and specific animal models have been used to identify the primary mechanism of action for promoting weight loss. LPT3-04™ appears to target fat cells and, specifically, induce cell death in white fat cells. This effect occurs in a dose-dependent fashion.
Regulatory Status. Oragenics is currently preparing to conduct a clinical study to support weight loss claims beginning during the third quarter of 2007. LPT3-04™ currently has GRAS (generally recognized as safe) status and could be marketed today as a food additive or nutritional supplement in the US. The company is seeking a commercial partner actively involved in weight loss products.
|